Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003557 |
---|---|
Receipt number | R000004284 |
Scientific Title | Postoperative adjuvant immunotherapy of tumor specific peptide vaccine for esophageal cancer patients with pathological lymph node metastasis who underwent preoperative therapy followed by surgery- single institute exploratory Phase II trial |
Date of disclosure of the study information | 2010/05/03 |
Last modified on | 2018/11/13 09:30:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/01 16:24:41 | ||
2 | Update | 2012/05/01 18:06:54 | Organization Organization Organization Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
3 | Update | 2015/02/24 22:51:51 | Email |
|
4 | Update | 2015/02/24 22:53:33 | Recruitment status |
|
5 | Update | 2015/05/01 18:54:29 | Publication of results |
|
6 | Update | 2015/05/01 18:59:14 | Last name of lead principal investigator Last name of lead principal investigator |
|
7 | Update | 2016/11/04 17:49:42 | Organization Organization Organization Name of primary person or sponsor Institute Department Organization Organization Organization Name of secondary funder(s) Name of secondary funder(s) Institutions |
|
8 | Update | 2017/05/06 10:19:57 | Public title Public title |
|
9 | Update | 2017/05/06 10:22:18 | Narrative objectives1 Narrative objectives1 |
|
10 | Update | 2017/05/06 10:34:18 | Address Address Address Organization Organization Category of Funding Organization Co-sponsor Co-sponsor Name of secondary funder(s) |
|
11 | Update | 2017/11/06 10:26:29 | Recruitment status Last follow-up date |
|
12 | Update | 2018/11/13 09:24:15 | Key secondary outcomes Key secondary outcomes |
|
13 | Update | 2018/11/13 09:28:11 | Email Name of secondary funder(s) Name of secondary funder(s) Email1 |
|
14 | Update | 2018/11/13 09:30:37 | Last follow-up date |